Clinical Trial Update: Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient [Phase 4]

View source ↗

Summary

Phase 4 trial investigating adding empagliflozin to insulin and oral antidiabetic therapy in poorly controlled type 2 diabetes with obesity; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Metabolism Disorders
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: SINA Health Education and Welfare Trust | Conditions: Glucose Metabolism Disorders, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED